SynthesisBMC women's health2017
Individual-level and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Nationwide survey.
Synthesis in BMC women's health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 7 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
65 citing papers in PubMed, 7 syntheses or guidelines pooled it.
- Exploring Women's Attitudes Towards Cervical Cancer Screening and Their Association with Life Satisfaction and General Life Attitudes: A Systematic Review.Asian Pacific journal of cancer prevention : APJCP · 2026Pooled it
- Cervical cancer screening uptake in East Africa: a systematic review and meta-analysis of observational studies.BMC public health · 2025Pooled it
- Sociocultural factors influencing women's adherence to colorectal, breast, and cervical cancer screening: a systematic review.BMC public health · 2025Pooled it
- Cervical cancer screening utilization among healthcare professionals in Ethiopia: systematic review and meta-analysis.Frontiers in global women's health · 2025Pooled it
- Applying the Health Belief Model to cervical cancer screening uptake among women in Ethiopia: a systematic review and meta-analysis.BMC cancer · 2024Pooled it
- Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review.BMC women's health · 2022Pooled it
- Cervical cancer screening utilization and predictors among eligible women in Ethiopia: A systematic review and meta-analysis.PloS one · 2021Pooled it
- Trial
- Effect of Socioeconomic Status on Cervical Cancer Screening Behaviour Among Mothers of Adolescent Girls in Lagos, Nigeria: A Secondary Analysis of theResearch square · 2026Article
- Article
- Association between mass media exposure and cervical cancer screening uptake among women aged 30-49 years in four sub-Saharan African countries: a pooled analysis of demographic and health surveys.BMC women's health · 2025Article
- Factors associated with cervical cancer screening among women attending maternal child health clinics in Kenya.BMC women's health · 2025Article
- Article
- Rural-urban disparities in cervical cancer screening uptake and its predictors among women aged 30-49 years in Ghana: a multivariate decomposition analysis.BMC women's health · 2025Article
- Determinants of cervical cancer screening uptake in Lesotho: evidence from 2024 Demographic and Health Survey data.BMC public health · 2025Article
- Article
- Factors associated with cervical cancer screening: results from cross-sectional surveys in Kenya and Malawi.BMC public health · 2025Article
- Article
- Factors Influencing Cervical Cancer Screening: A Cross-Sectional Study Among Ethnically Diverse Women in the Kumasi Metropolis of Ghana.Health science reports · 2025Article
- Article
5 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundStudies on the determinants of cervical cancer screening in sub-Saharan Africa have focused mostly on individual-level characteristics of cervical cancer screening. Therefore, in this study, we included both individual- and community-level indicators to examine the determinants of cervical cancer screening among Kenyan women.
methodsWe analyzed data from the 2014 Kenya Demographic and Health Surveys. Our analysis focused on 9016 married women of reproductive age (15-49 years). We conducted multilevel analyses using generalized linear mixed models with the log-binomial function to simultaneously analyze the association of individual- and community-level factors with cervical cancer screening.
resultsAbout 72.1% of women (n = 6498) knew about cervical cancer. Of these women, only 19.4% had undergone cervical cancer screening [58.24% Papanicolaou (Pap) test and 41.76% visual inspection]. Our multivariate analysis results indicated that the prevalence of cervical cancer screening was higher among women aged 35-49 years than women aged 15-24 years. The prevalence was also higher among women residing in the Central, Nyanza, and Nairobi regions than women residing in the Coastal region. Cervical cancer screening was more prevalent among women who had media exposure, had higher household wealth index, were employed, were insured, and had visit a health facility in 12 months than did their counterparts. The prevalence of Pap test history was 19% higher among women who had sexual autonomy than women who did not have sexual autonomy. The prevalence of Pap test history was also higher among communities comprised of higher proportions of women with sexual autonomy and higher education.
conclusionsPolicies should emphasize increasing gender equality, improving education at the community level, providing employment opportunities for women, and increasing universal health insurance coverage. These focal points can ensure equity in access to health care services and further increase the prevalence of cervical cancer screening in Kenya.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.